Milrinone is preferred to levosimendan for mesenteric perfusion in hypoxia-reoxygenated newborn piglets treated with dopamine
Introduction: There is little information regarding the comparative hemodynamic effects of adding milrinone or levosimendan to dopamine infusion in hypoxia-reoxygenated (H-R) newborns. Results: Severely hypoxic piglets had cardiogenic shock with depressed cardiac index (CI) and mean arterial pressur...
Gespeichert in:
Veröffentlicht in: | Pediatric research 2012-03, Vol.71 (3), p.241-246 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 246 |
---|---|
container_issue | 3 |
container_start_page | 241 |
container_title | Pediatric research |
container_volume | 71 |
creator | Manouchehri, Namdar Bigam, David L. Churchill, Thomas Joynt, Chloe Vento, Maximo Cheung, Po-Yin |
description | Introduction:
There is little information regarding the comparative hemodynamic effects of adding milrinone or levosimendan to dopamine infusion in hypoxia-reoxygenated (H-R) newborns.
Results:
Severely hypoxic piglets had cardiogenic shock with depressed cardiac index (CI) and mean arterial pressure (MAP). The hemodynamics deteriorated gradually after initial recovery upon reoxygenation. Heart rate and CI improved with milrinone (D+M) and levosimendan (D+L) administration (
P
< 0.05 vs. control). Both regimens improved carotid arterial flow and carotid vascular resistance; D+M additionally improved superior mesentric arterial flow (all
P
< 0.05 vs. control). No effect was found on renal arterial flow or elevated lactate state with either regimen. D+M piglets also had a lower myocardial oxidized/reduced glutathione ratio (
P
< 0.05 vs. control).
Discussion:
In conclusion, adding milrinone or levosimendan to dopamine similarly improved systemic hemodynamics in H-R newborn piglets. Milrinone also improved mesenteric perfusion and attenuated myocardial oxidative stress.
Methods:
Twenty-eight piglets (1–4 d, 1.5–2.5 kg) were instrumented for continuous monitoring of systemic MAP and pulmonary arterial pressure (PAP), CI, and carotid, superior mesenteric, and renal arterial flows. Piglets were randomized with blinding to sham-operated, H-R control (saline), and H-R dopamine (10 μg/kg/min) with D+M or D+L groups. H-R piglets underwent H-R followed by 2 h of drug infusion after reoxygenation. Tissue was collected for biochemical/oxidative stress testing and histological analysis. |
doi_str_mv | 10.1038/pr.2011.48 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4972574</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>22337258</sourcerecordid><originalsourceid>FETCH-LOGICAL-c443t-c315db2be227e687a2773236ac8c206264b8348048c63bd07b6436c5c11f354d3</originalsourceid><addsrcrecordid>eNptkU1P3DAQhq0KVBbaS39A5UsvRdn6K4n3UqlCfElUvbRny3Emu0aJHY2zLHvgv2NYoCBxssbzzPtq3iHkC2dzzqT-MeJcMM7nSn8gM15KVjCl6j0yY0zyQi4W-oAcpnTNGFelVh_JgRBS1qLUM3L32_foQwxAfaIjQgeI0NIp0h5uYvIDhNYG2kWkAyQIE6B3dATs1snHQH2gq-0Yb70tEOLtdgnBTlkgwKaJGOjolz1MiU4Ij_8bP61oG0c7-ACfyH5n-wSfn94j8u_s9O_JRXH15_zy5NdV4ZSSU-EkL9tGNCBEDZWurahrKWRlnXaCVaJSjZZKM6VdJZuW1U2lZOVKx3knS9XKI_JzpzuumwFal9dA25sR_WBxa6L15m0n-JVZxhujFjmmWmWB7zsBhzGlnNLLLGfm4Qi5Ng9HMEpn-Otrtxf0OfUMfHsCbHK279AG59N_rqwY27ke77iUW2EJaK7jGkNO6j3be6h4obA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Milrinone is preferred to levosimendan for mesenteric perfusion in hypoxia-reoxygenated newborn piglets treated with dopamine</title><source>MEDLINE</source><source>SpringerLink Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Manouchehri, Namdar ; Bigam, David L. ; Churchill, Thomas ; Joynt, Chloe ; Vento, Maximo ; Cheung, Po-Yin</creator><creatorcontrib>Manouchehri, Namdar ; Bigam, David L. ; Churchill, Thomas ; Joynt, Chloe ; Vento, Maximo ; Cheung, Po-Yin</creatorcontrib><description>Introduction:
There is little information regarding the comparative hemodynamic effects of adding milrinone or levosimendan to dopamine infusion in hypoxia-reoxygenated (H-R) newborns.
Results:
Severely hypoxic piglets had cardiogenic shock with depressed cardiac index (CI) and mean arterial pressure (MAP). The hemodynamics deteriorated gradually after initial recovery upon reoxygenation. Heart rate and CI improved with milrinone (D+M) and levosimendan (D+L) administration (
P
< 0.05 vs. control). Both regimens improved carotid arterial flow and carotid vascular resistance; D+M additionally improved superior mesentric arterial flow (all
P
< 0.05 vs. control). No effect was found on renal arterial flow or elevated lactate state with either regimen. D+M piglets also had a lower myocardial oxidized/reduced glutathione ratio (
P
< 0.05 vs. control).
Discussion:
In conclusion, adding milrinone or levosimendan to dopamine similarly improved systemic hemodynamics in H-R newborn piglets. Milrinone also improved mesenteric perfusion and attenuated myocardial oxidative stress.
Methods:
Twenty-eight piglets (1–4 d, 1.5–2.5 kg) were instrumented for continuous monitoring of systemic MAP and pulmonary arterial pressure (PAP), CI, and carotid, superior mesenteric, and renal arterial flows. Piglets were randomized with blinding to sham-operated, H-R control (saline), and H-R dopamine (10 μg/kg/min) with D+M or D+L groups. H-R piglets underwent H-R followed by 2 h of drug infusion after reoxygenation. Tissue was collected for biochemical/oxidative stress testing and histological analysis.</description><identifier>ISSN: 0031-3998</identifier><identifier>EISSN: 1530-0447</identifier><identifier>DOI: 10.1038/pr.2011.48</identifier><identifier>PMID: 22337258</identifier><identifier>CODEN: PEREBL</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>631/92/436 ; 692/699/75 ; Animals ; Animals, Newborn - physiology ; Biological and medical sciences ; Cardiotonic Agents - pharmacology ; Cardiotonic Agents - therapeutic use ; Dopamine - pharmacology ; Dopamine - therapeutic use ; Drug Therapy, Combination ; General aspects ; Hemodynamics - drug effects ; Hemodynamics - physiology ; Hydrazones - pharmacology ; Hydrazones - therapeutic use ; Hypoxia - drug therapy ; Medical sciences ; Medicine ; Medicine & Public Health ; Mesenteric Arteries - drug effects ; Milrinone - pharmacology ; Milrinone - therapeutic use ; Models, Animal ; Myocardial Reperfusion - methods ; Myocardial Reperfusion Injury - prevention & control ; Oxidative Stress - drug effects ; Oxidative Stress - physiology ; Pediatric Surgery ; Pediatrics ; Pyridazines - pharmacology ; Pyridazines - therapeutic use ; Swine ; translational-investigation ; Vasodilator Agents - pharmacology ; Vasodilator Agents - therapeutic use</subject><ispartof>Pediatric research, 2012-03, Vol.71 (3), p.241-246</ispartof><rights>International Pediatric Research Foundation, Inc. 2012</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c443t-c315db2be227e687a2773236ac8c206264b8348048c63bd07b6436c5c11f354d3</citedby><cites>FETCH-LOGICAL-c443t-c315db2be227e687a2773236ac8c206264b8348048c63bd07b6436c5c11f354d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/pr.2011.48$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/pr.2011.48$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25600574$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22337258$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Manouchehri, Namdar</creatorcontrib><creatorcontrib>Bigam, David L.</creatorcontrib><creatorcontrib>Churchill, Thomas</creatorcontrib><creatorcontrib>Joynt, Chloe</creatorcontrib><creatorcontrib>Vento, Maximo</creatorcontrib><creatorcontrib>Cheung, Po-Yin</creatorcontrib><title>Milrinone is preferred to levosimendan for mesenteric perfusion in hypoxia-reoxygenated newborn piglets treated with dopamine</title><title>Pediatric research</title><addtitle>Pediatr Res</addtitle><addtitle>Pediatr Res</addtitle><description>Introduction:
There is little information regarding the comparative hemodynamic effects of adding milrinone or levosimendan to dopamine infusion in hypoxia-reoxygenated (H-R) newborns.
Results:
Severely hypoxic piglets had cardiogenic shock with depressed cardiac index (CI) and mean arterial pressure (MAP). The hemodynamics deteriorated gradually after initial recovery upon reoxygenation. Heart rate and CI improved with milrinone (D+M) and levosimendan (D+L) administration (
P
< 0.05 vs. control). Both regimens improved carotid arterial flow and carotid vascular resistance; D+M additionally improved superior mesentric arterial flow (all
P
< 0.05 vs. control). No effect was found on renal arterial flow or elevated lactate state with either regimen. D+M piglets also had a lower myocardial oxidized/reduced glutathione ratio (
P
< 0.05 vs. control).
Discussion:
In conclusion, adding milrinone or levosimendan to dopamine similarly improved systemic hemodynamics in H-R newborn piglets. Milrinone also improved mesenteric perfusion and attenuated myocardial oxidative stress.
Methods:
Twenty-eight piglets (1–4 d, 1.5–2.5 kg) were instrumented for continuous monitoring of systemic MAP and pulmonary arterial pressure (PAP), CI, and carotid, superior mesenteric, and renal arterial flows. Piglets were randomized with blinding to sham-operated, H-R control (saline), and H-R dopamine (10 μg/kg/min) with D+M or D+L groups. H-R piglets underwent H-R followed by 2 h of drug infusion after reoxygenation. Tissue was collected for biochemical/oxidative stress testing and histological analysis.</description><subject>631/92/436</subject><subject>692/699/75</subject><subject>Animals</subject><subject>Animals, Newborn - physiology</subject><subject>Biological and medical sciences</subject><subject>Cardiotonic Agents - pharmacology</subject><subject>Cardiotonic Agents - therapeutic use</subject><subject>Dopamine - pharmacology</subject><subject>Dopamine - therapeutic use</subject><subject>Drug Therapy, Combination</subject><subject>General aspects</subject><subject>Hemodynamics - drug effects</subject><subject>Hemodynamics - physiology</subject><subject>Hydrazones - pharmacology</subject><subject>Hydrazones - therapeutic use</subject><subject>Hypoxia - drug therapy</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Mesenteric Arteries - drug effects</subject><subject>Milrinone - pharmacology</subject><subject>Milrinone - therapeutic use</subject><subject>Models, Animal</subject><subject>Myocardial Reperfusion - methods</subject><subject>Myocardial Reperfusion Injury - prevention & control</subject><subject>Oxidative Stress - drug effects</subject><subject>Oxidative Stress - physiology</subject><subject>Pediatric Surgery</subject><subject>Pediatrics</subject><subject>Pyridazines - pharmacology</subject><subject>Pyridazines - therapeutic use</subject><subject>Swine</subject><subject>translational-investigation</subject><subject>Vasodilator Agents - pharmacology</subject><subject>Vasodilator Agents - therapeutic use</subject><issn>0031-3998</issn><issn>1530-0447</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkU1P3DAQhq0KVBbaS39A5UsvRdn6K4n3UqlCfElUvbRny3Emu0aJHY2zLHvgv2NYoCBxssbzzPtq3iHkC2dzzqT-MeJcMM7nSn8gM15KVjCl6j0yY0zyQi4W-oAcpnTNGFelVh_JgRBS1qLUM3L32_foQwxAfaIjQgeI0NIp0h5uYvIDhNYG2kWkAyQIE6B3dATs1snHQH2gq-0Yb70tEOLtdgnBTlkgwKaJGOjolz1MiU4Ij_8bP61oG0c7-ACfyH5n-wSfn94j8u_s9O_JRXH15_zy5NdV4ZSSU-EkL9tGNCBEDZWurahrKWRlnXaCVaJSjZZKM6VdJZuW1U2lZOVKx3knS9XKI_JzpzuumwFal9dA25sR_WBxa6L15m0n-JVZxhujFjmmWmWB7zsBhzGlnNLLLGfm4Qi5Ng9HMEpn-Otrtxf0OfUMfHsCbHK279AG59N_rqwY27ke77iUW2EJaK7jGkNO6j3be6h4obA</recordid><startdate>20120301</startdate><enddate>20120301</enddate><creator>Manouchehri, Namdar</creator><creator>Bigam, David L.</creator><creator>Churchill, Thomas</creator><creator>Joynt, Chloe</creator><creator>Vento, Maximo</creator><creator>Cheung, Po-Yin</creator><general>Nature Publishing Group US</general><general>Lippincott Williams & Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20120301</creationdate><title>Milrinone is preferred to levosimendan for mesenteric perfusion in hypoxia-reoxygenated newborn piglets treated with dopamine</title><author>Manouchehri, Namdar ; Bigam, David L. ; Churchill, Thomas ; Joynt, Chloe ; Vento, Maximo ; Cheung, Po-Yin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c443t-c315db2be227e687a2773236ac8c206264b8348048c63bd07b6436c5c11f354d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>631/92/436</topic><topic>692/699/75</topic><topic>Animals</topic><topic>Animals, Newborn - physiology</topic><topic>Biological and medical sciences</topic><topic>Cardiotonic Agents - pharmacology</topic><topic>Cardiotonic Agents - therapeutic use</topic><topic>Dopamine - pharmacology</topic><topic>Dopamine - therapeutic use</topic><topic>Drug Therapy, Combination</topic><topic>General aspects</topic><topic>Hemodynamics - drug effects</topic><topic>Hemodynamics - physiology</topic><topic>Hydrazones - pharmacology</topic><topic>Hydrazones - therapeutic use</topic><topic>Hypoxia - drug therapy</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Mesenteric Arteries - drug effects</topic><topic>Milrinone - pharmacology</topic><topic>Milrinone - therapeutic use</topic><topic>Models, Animal</topic><topic>Myocardial Reperfusion - methods</topic><topic>Myocardial Reperfusion Injury - prevention & control</topic><topic>Oxidative Stress - drug effects</topic><topic>Oxidative Stress - physiology</topic><topic>Pediatric Surgery</topic><topic>Pediatrics</topic><topic>Pyridazines - pharmacology</topic><topic>Pyridazines - therapeutic use</topic><topic>Swine</topic><topic>translational-investigation</topic><topic>Vasodilator Agents - pharmacology</topic><topic>Vasodilator Agents - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Manouchehri, Namdar</creatorcontrib><creatorcontrib>Bigam, David L.</creatorcontrib><creatorcontrib>Churchill, Thomas</creatorcontrib><creatorcontrib>Joynt, Chloe</creatorcontrib><creatorcontrib>Vento, Maximo</creatorcontrib><creatorcontrib>Cheung, Po-Yin</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Pediatric research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Manouchehri, Namdar</au><au>Bigam, David L.</au><au>Churchill, Thomas</au><au>Joynt, Chloe</au><au>Vento, Maximo</au><au>Cheung, Po-Yin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Milrinone is preferred to levosimendan for mesenteric perfusion in hypoxia-reoxygenated newborn piglets treated with dopamine</atitle><jtitle>Pediatric research</jtitle><stitle>Pediatr Res</stitle><addtitle>Pediatr Res</addtitle><date>2012-03-01</date><risdate>2012</risdate><volume>71</volume><issue>3</issue><spage>241</spage><epage>246</epage><pages>241-246</pages><issn>0031-3998</issn><eissn>1530-0447</eissn><coden>PEREBL</coden><abstract>Introduction:
There is little information regarding the comparative hemodynamic effects of adding milrinone or levosimendan to dopamine infusion in hypoxia-reoxygenated (H-R) newborns.
Results:
Severely hypoxic piglets had cardiogenic shock with depressed cardiac index (CI) and mean arterial pressure (MAP). The hemodynamics deteriorated gradually after initial recovery upon reoxygenation. Heart rate and CI improved with milrinone (D+M) and levosimendan (D+L) administration (
P
< 0.05 vs. control). Both regimens improved carotid arterial flow and carotid vascular resistance; D+M additionally improved superior mesentric arterial flow (all
P
< 0.05 vs. control). No effect was found on renal arterial flow or elevated lactate state with either regimen. D+M piglets also had a lower myocardial oxidized/reduced glutathione ratio (
P
< 0.05 vs. control).
Discussion:
In conclusion, adding milrinone or levosimendan to dopamine similarly improved systemic hemodynamics in H-R newborn piglets. Milrinone also improved mesenteric perfusion and attenuated myocardial oxidative stress.
Methods:
Twenty-eight piglets (1–4 d, 1.5–2.5 kg) were instrumented for continuous monitoring of systemic MAP and pulmonary arterial pressure (PAP), CI, and carotid, superior mesenteric, and renal arterial flows. Piglets were randomized with blinding to sham-operated, H-R control (saline), and H-R dopamine (10 μg/kg/min) with D+M or D+L groups. H-R piglets underwent H-R followed by 2 h of drug infusion after reoxygenation. Tissue was collected for biochemical/oxidative stress testing and histological analysis.</abstract><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>22337258</pmid><doi>10.1038/pr.2011.48</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0031-3998 |
ispartof | Pediatric research, 2012-03, Vol.71 (3), p.241-246 |
issn | 0031-3998 1530-0447 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4972574 |
source | MEDLINE; SpringerLink Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | 631/92/436 692/699/75 Animals Animals, Newborn - physiology Biological and medical sciences Cardiotonic Agents - pharmacology Cardiotonic Agents - therapeutic use Dopamine - pharmacology Dopamine - therapeutic use Drug Therapy, Combination General aspects Hemodynamics - drug effects Hemodynamics - physiology Hydrazones - pharmacology Hydrazones - therapeutic use Hypoxia - drug therapy Medical sciences Medicine Medicine & Public Health Mesenteric Arteries - drug effects Milrinone - pharmacology Milrinone - therapeutic use Models, Animal Myocardial Reperfusion - methods Myocardial Reperfusion Injury - prevention & control Oxidative Stress - drug effects Oxidative Stress - physiology Pediatric Surgery Pediatrics Pyridazines - pharmacology Pyridazines - therapeutic use Swine translational-investigation Vasodilator Agents - pharmacology Vasodilator Agents - therapeutic use |
title | Milrinone is preferred to levosimendan for mesenteric perfusion in hypoxia-reoxygenated newborn piglets treated with dopamine |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T21%3A51%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Milrinone%20is%20preferred%20to%20levosimendan%20for%20mesenteric%20perfusion%20in%20hypoxia-reoxygenated%20newborn%20piglets%20treated%20with%20dopamine&rft.jtitle=Pediatric%20research&rft.au=Manouchehri,%20Namdar&rft.date=2012-03-01&rft.volume=71&rft.issue=3&rft.spage=241&rft.epage=246&rft.pages=241-246&rft.issn=0031-3998&rft.eissn=1530-0447&rft.coden=PEREBL&rft_id=info:doi/10.1038/pr.2011.48&rft_dat=%3Cpubmed_cross%3E22337258%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/22337258&rfr_iscdi=true |